跳到正文
原文
pharmalot· @pharmalot · X·· 2026-08-04AI 评分22
AI 导读

Pharmalittle:我们正在关注礼来的一项可及性计划、吉利德在一项"新颖"理论上的法庭胜利,以及更多新闻.. https://www.statnews.com/pharmalot/2026/08/04/lilly-expands-retatrutide-access-program-gilead-court-victory/ #pharma #Lilly #Gilead #obesity #HIV #medicines #CVS #raredisease #orphandrug $GILD $LLY $CVS $RYTM

正文

Pharmalittle: We’re reading about a Lilly access program, a Gilead court victory over a 'novel' theory, and more news.. https://www.statnews.com/pharmalot/2026/08/04/lilly-expands-retatrutide-access-program-gilead-court-victory/ #pharma #Lilly #Gilead #obesity #HIV #medicines #CVS #raredisease #orphandrug $GILD $LLY $CVS $RYTM

来源:pharmalot · x.com